Preliminary Results of MT-401 in Post-Transplant Measurable Residual Disease Positive (MRD plus ) Acute Myeloid Leukemia (AML) Patients

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2022)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要